These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 16239177)

  • 1. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial.
    Lux AL; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP;
    Lancet Neurol; 2005 Nov; 4(11):712-7. PubMed ID: 16239177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi-centre randomised trial.
    Darke K; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Lux AL; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP;
    Arch Dis Child; 2010 May; 95(5):382-6. PubMed ID: 20457702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial.
    O'Callaghan FJK; Edwards SW; Alber FD; Cortina Borja M; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay MT; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
    Lancet Child Adolesc Health; 2018 Oct; 2(10):715-725. PubMed ID: 30236380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial.
    Lux AL; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP
    Lancet; 2004 Nov 13-19; 364(9447):1773-8. PubMed ID: 15541450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial.
    O'Callaghan FJ; Edwards SW; Alber FD; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay M; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
    Lancet Neurol; 2017 Jan; 16(1):33-42. PubMed ID: 27838190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: evidence from the United Kingdom Infantile Spasms Study.
    O'Callaghan FJ; Lux AL; Darke K; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; Verity CM; Osborne JP
    Epilepsia; 2011 Jul; 52(7):1359-64. PubMed ID: 21668442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prednisolone or tetracosactide depot for infantile epileptic spasms syndrome? A prospective analysis of data embedded within two randomised controlled trials.
    Osborne JP; Edwards SW; Alber FD; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay M; Mallick A; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; O'Callaghan FK
    Eur J Paediatr Neurol; 2023 Jan; 42():110-116. PubMed ID: 36621063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of infantile spasms.
    Hancock EC; Osborne JP; Edwards SW
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD001770. PubMed ID: 23740534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome in children with infantile spasms treated with vigabatrin: a cohort of 180 patients.
    Djuric M; Kravljanac R; Tadic B; Mrlješ-Popovic N; Appleton RE
    Epilepsia; 2014 Dec; 55(12):1918-25. PubMed ID: 25377998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vigabatrin for infantile spasms.
    Pesaturo KA; Spooner LM; Belliveau P
    Pharmacotherapy; 2011 Mar; 31(3):298-311. PubMed ID: 21361740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to sequential treatment with prednisolone and vigabatrin in infantile spasms.
    Dzau W; Cheng S; Snell P; Fahey M; Scheffer IE; Harvey AS; Howell KB
    J Paediatr Child Health; 2022 Dec; 58(12):2197-2202. PubMed ID: 36054157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seizure outcome in infantile spasms--a retrospective study.
    Mohamed BP; Scott RC; Desai N; Gutta P; Patil S
    Epilepsia; 2011 Apr; 52(4):746-52. PubMed ID: 21320111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vigabatrin and high-dose prednisolone therapy for patients with West syndrome.
    Ko A; Youn SE; Chung HJ; Kim SH; Lee JS; Kim HD; Kang HC
    Epilepsy Res; 2018 Sep; 145():127-133. PubMed ID: 29966811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of West syndrome].
    Cvitanović-Sojat L; Gjergja R; Sabol Z; Hajnzić TF; Sojat T
    Acta Med Croatica; 2005; 59(1):19-29. PubMed ID: 15813352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective preliminary analysis of the development of autism and epilepsy in children with infantile spasms.
    Askalan R; Mackay M; Brian J; Otsubo H; McDermott C; Bryson S; Boyd J; Snead C; Roberts W; Weiss S
    J Child Neurol; 2003 Mar; 18(3):165-70. PubMed ID: 12731640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A risk-benefit assessment of treatments for infantile spasms.
    Nabbout R
    Drug Saf; 2001; 24(11):813-28. PubMed ID: 11665869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vigabatrin therapy for infantile spasms: review of major trials in Europe, Canada, and the United States; and recommendations for dosing.
    Carmant L
    Acta Neurol Scand Suppl; 2011; (192):36-47. PubMed ID: 22061179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of hypsarrhythmia on infantile spasms treatment response: Observational cohort study from the National Infantile Spasms Consortium.
    Demarest ST; Shellhaas RA; Gaillard WD; Keator C; Nickels KC; Hussain SA; Loddenkemper T; Patel AD; Saneto RP; Wirrell E; Sánchez Fernández I; Chu CJ; Grinspan Z; Wusthoff CJ; Joshi S; Mohamed IS; Stafstrom CE; Stack CV; Yozawitz E; Bluvstein JS; Singh RK; Knupp KG;
    Epilepsia; 2017 Dec; 58(12):2098-2103. PubMed ID: 29105055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical profile and treatment of infantile spasms using vigabatrin and ACTH--a developing country perspective.
    Ibrahim S; Gulab S; Ishaque S; Saleem T
    BMC Pediatr; 2010 Jan; 10():1. PubMed ID: 20078871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vigabatrin as First-Line Treatment for Infantile Spasms Not Related to Tuberous Sclerosis Complex.
    Jones K; Go C; Boyd J; Ochi A; McCoy B; Puka K; Snead OC
    Pediatr Neurol; 2015 Aug; 53(2):141-5. PubMed ID: 26227562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.